CIK: 0001582844 · Show all filings
Period: Q1 2020 (← Previous) (Next →)
Filing Date: May 15, 2020
Total Value ($000): $206,318 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | AVADEL PHARMACEUTICALS PLC | 2,673,718 | $20,949 | 10.2% | $7.66 | — | SPONSORED ADR | 05337M104 |
| AXSM | AXSOME THERAPEUTICS INC | 308,500 | $18,149 | 8.8% | $23.68 | +244.1% | COM | 05464T104 |
| — | ADVERUM BIOTECHNOLOGIES INC | 1,704,500 | $16,653 | 8.1% | $11.13 | — | COM | 00773U108 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 399,500 | $11,959 | 5.8% | $7.92 | +234.8% | COM | 462260100 |
| ARVN | ARVINAS INC | 280,120 | $11,289 | 5.5% | $19.30 | +142.4% | COM | 04335A105 |
| AUPH | AURINIA PHARMACEUTICALS INC | 770,000 | $11,173 | 5.4% | $6.93 | +154.5% | COM | 05156V102 |
| — | BELLUS HEALTH INC NEW | 1,070,000 | $10,679 | 5.2% | $7.29 | — | COM NEW | 07987C204 |
| — | KADMON HLDGS INC | 2,360,000 | $9,888 | 4.8% | $3.68 | — | COM | 48283N106 |
| — | VERASTEM INC | 3,720,930 | $9,496 | 4.6% | $2.55 | — | COM | 92337C104 |
| XENE | XENON PHARMACEUTICALS INC | 628,500 | $7,127 | 3.5% | $8.16 | +74.6% | COM | 98420N105 |
| ASND | ASCENDIS PHARMA A S | 63,200 | $7,117 | 3.4% | $122.05 | — | SPONSORED ADR | 04351P101 |
| — | BIOXCEL THERAPEUTICS INC | 315,000 | $7,040 | 3.4% | $22.35 | — | COM | 09075P105 |
| — | CATALYST BIOSCIENCES INC | 1,384,600 | $6,051 | 2.9% | $4.37 | — | COM NEW | 14888D208 |
| — | SELECTA BIOSCIENCES INC | 2,364,204 | $5,698 | 2.8% | $2.26 | — | COM | 816212104 |
| APLS | APELLIS PHARMACEUTICALS INC | 209,500 | $5,613 | 2.7% | $28.50 | +24.6% | COM | 03753U106 |
| — | LIFESCI ACQUISITION CORP | 560,000 | $5,599 | 2.7% | $10.00 | — | UNIT 03/31/2025 | 53228P208 |
| — | MERSANA THERAPEUTICS INC | 827,500 | $4,824 | 2.3% | $5.83 | — | COM | 59045L106 |
| — | DICERNA PHARMACEUTICALS INC | 256,500 | $4,712 | 2.3% | $22.03 | — | COM | 253031108 |
| — | CONSTELLATION PHARMCETICLS I | 139,464 | $4,383 | 2.1% | $47.11 | — | COM | 210373106 |
| — | KARUNA THERAPEUTICS INC | 56,000 | $4,032 | 2.0% | $75.34 | — | COM | 48576A100 |
| — | REATA PHARMACEUTICALS INC | 23,500 | $3,392 | 1.6% | $80.29 | — | CL A | 75615P103 |
| — | APPLIED THERAPEUTICS INC | 102,000 | $3,334 | 1.6% | $18.14 | — | COM | 03828A101 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 109,700 | $3,156 | 1.5% | $23.72 | +70.1% | COM | 04280A100 |
| RLMD | RELMADA THERAPEUTICS INC | 90,950 | $3,102 | 1.5% | $40.32 | 0.0% | COM | 75955J402 |
| QURE | UNIQURE NV | 53,000 | $2,515 | 1.2% | $56.25 | +2.1% | SHS | N90064101 |
| — | MARINUS PHARMACEUTICALS INC | 1,038,000 | $2,107 | 1.0% | $2.03 | — | COM | 56854Q101 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 39,000 | $1,993 | 1.0% | $51.10 | — | COM | 37890U108 |
| KURA | KURA ONCOLOGY INC | 198,000 | $1,970 | 1.0% | $16.00 | -28.5% | COM | 50127T109 |
| — | ZAFGEN INC | 1,386,000 | $1,067 | 0.5% | $1.02 | — | COM | 98885E103 |
| BCRX | BIOCRYST PHARMACEUTICALS | 250,000 | $500 | 0.2% | $2.52 | +9.5% | COM | 09058V103 |
| — | IVERIC BIO INC | 139,000 | $478 | 0.2% | $8.58 | — | COM | 46583P102 |
| ABUS | ARBUTUS BIOPHARMA CORP | 269,907 | $273 | 0.1% | $2.70 | 0.0% | COM | 03879J100 |